Insider · CIK 0001958648
Nicolas Link
Files at QIND (Quality Industrial Corp.). First filing -, latest -.
Nicolas Link files SEC Form 4 as director and 10% owner at QIND (Quality Industrial Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nicolas Link has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | QIND Quality Industrial Corp. | DDisposition to issuer Common Stockindirect: Ilustrato Pictures International Inc. | -57,669,078 | $0.00 | $0 | 0 | Nov 29, 2024 |
| Nov 26, 2024 | QIND Quality Industrial Corp. | DDisposition to issuer Common Stock | -4,750,000 | $0.00 | $0 | 0 | Nov 29, 2024 |
| Nov 26, 2024 | QIND Quality Industrial Corp. | DDisposition to issuer Series A Stockindirect: Ilustrato Pictures International Inc. | -20,000 | $0.00 | $0 | 0 | Nov 29, 2024 |
Questions about Nicolas Link
Answered from the filings on this page, as of the latest one.
Is Nicolas Link buying or selling?
Nicolas Link has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nicolas Link's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nicolas Link has 0.
Where does Nicolas Link file Form 4?
Nicolas Link has filed Form 4 at QIND (Quality Industrial Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.